Roche

AI healthcare integration expands via agents and RCM

17 clusters · 80 sources · last updated 2 days ago

Latest: Medical AI companies expand automation for healthcare revenue cycles

Since the July 2026 summit, AI deployment in healthcare has accelerated toward a collaborative model. While AI automates repetitive tasks, experts emphasize that human judgment remains essential for medical coding, clini

Advancements in Alzheimer's blood tests, AI, and drug safety

13 clusters · 67 sources · last updated 2 days ago

Latest: Alzheimer’s detection advances through AI and blood testing

Research into Alzheimer's biomarkers continues to evolve, with recent findings refining the utility of blood-based testing. While plasma p-tau217 remains a key indicator, studies suggest its predictive power in symptom-f

Global pharmaceutical and oncology market growth projections

5 clusters · 7 sources · last updated 6 days ago

Latest: Global cancer therapy markets projected to grow significantly by 2030

The global pharmaceutical and oncology markets are projected to experience substantial growth through the early 2030s, driven by innovative therapies and advancements in diagnostics. While total pharmaceutical spending i

Alzheimer's disease prevention research

2 clusters · 7 sources · last updated 6 days ago

Latest: Alzheimer's research shifts toward early intervention and disease-modifying therapies

The international PrevenTRON Phase III clinical trial is investigating the efficacy of the drug Trontinemab in preventing the onset of Alzheimer’s disease in asymptomatic individuals. The study aims to recruit approximat

Global food safety and counterfeit medication alerts

3 clusters · 26 sources · last updated 15 days ago

Latest: Pharmaceutical safety concerns rise in Chile and Panama

Health authorities across several regions continue to issue warnings regarding contaminated food products and counterfeit or unregistered medications. In South and Central America, medication shortages and regulatory br

Chinese biopharmaceutical global expansion and growth

2 clusters · 8 sources · last updated 16 days ago

Latest: Biotech firms Simnova and Simcere Zaiming secure major funding and licensing deals

Chinese biopharmaceutical companies are reporting significant financial growth and expanding their global presence through international licensing deals and research funding. In mid-2026, 3S Bio reported a 3.9% year-ove

AI and machine learning in fatty liver disease research

2 clusters · 4 sources · last updated 20 days ago

Latest: Machine learning advances dietary and liver disease detection

Researchers are increasingly employing artificial intelligence and machine learning to address the global fatty liver disease crisis. Early efforts have focused on using AI models to analyze electronic medical records, b

Advancements in Alzheimer's blood test detection

2 clusters · 4 sources · last updated 21 days ago

Latest: FDA clears two new blood tests for Alzheimer's detection

Research led by neurologist Allal Boutjankout and NYU professor Thomas Wisniewski demonstrated that blood tests measuring plasma levels of beta-amyloid, tau, and inflammation-related proteins can identify Alzheimer’s dis

Hanmi Pharmaceutical obesity drug development

2 clusters · 13 sources · last updated 22 days ago

Latest: Hanmi Pharmaceutical to produce documentary on obesity drug Epe

Hanmi Pharmaceutical is advancing its obesity and metabolic disease drug pipeline through both international licensing and domestic development. In late August 2026, Hanmi entered an exclusive licensing agreement with G

Duchenne muscular dystrophy drug regulation in Brazil

2 clusters · 35 sources · last updated 23 days ago

Latest: Anvisa and Roche cancel Elevidys registration in Brazil

In August 2026, Brazil’s National Health Surveillance Agency (Anvisa) issued two significant regulatory decisions regarding treatments for Duchenne muscular dystrophy (DMD). First, Anvisa approved the registration of Du

Swiss stock market performance and semiconductor volatility

2 clusters · 25 sources · last updated 23 days ago

Latest: NVIDIA earnings and AMD market share drive semiconductor sector focus

The Swiss stock market has transitioned from a period of heightened caution and technical warnings to a state of mixed performance influenced by global factors. Initially, market sentiment shifted toward a “risk-off” st

Replimune Tudriqev FDA approval and subsequent legal action

5 clusters · 20 sources · last updated 24 days ago

Latest: Replimune faces lawsuits following TUDRIQEV approval

On 6 August 2026, the FDA granted accelerated approval to Replimune’s oncolytic herpes-virus therapy RP1, marketed as Tudriqev, for use with Bristol Myers Squibb’s Opdivo (nivolumab) in adults with unresectable or metast

Market forecast reports expand across sectors

6 clusters · 12 sources · last updated 28 days ago

Latest: Genomics and genetic analysis markets projected for significant global growth

In late July 2026, a wave of market-research publications projected robust growth for various industries, including crop-insurance, genomics, and semiconductor metrology. Around the same time, Japanese distributor SEMABI

Impact of U.S. drug pricing on international medicine access

2 clusters · 7 sources · last updated 30 days ago

Latest: U.S. drug pricing policy delays medicine rollouts in Canada

Pharmaceutical companies are delaying or cancelling the launch of new medications in international markets, specifically Switzerland and Canada, citing concerns over United States drug-pricing policies. In Switzerland,

Rinvoq approval for vitiligo treatment

2 clusters · 3 sources · last updated about 1 month ago

Latest: UAE approves first oral medication for vitiligo treatment

The United Arab Emirates has granted approval for the oral use of Rinvoq (upadacitinib) to treat non-segmental vitiligo. This marks the first time the medication has been approved for oral use for this condition globally